Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

IMV Announces Final Topline Results of the DeCidE1 Clinical Trial in Advanced Recurrent Ovarian …,

Final patient completed the study after more than 2 years of clinical benefits with maveropepimut-S (MVP-S). Median Overall Survival was 19.9 months …, Final patient completed the study after more than 2 years of clinical benefits with maveropepimut-S (MVP-S). Median Overall Survival was 19.9 months …, Read More

Scroll to Top